11:16:04 EDT Fri 10 May 2024
Enter Symbol
or Name
USA
CA



Hamilton Thorne Ltd
Symbol HTL
Shares Issued 151,823,695
Close 2023-11-07 C$ 1.48
Market Cap C$ 224,699,069
Recent Sedar Documents

Hamilton Thorne to release Q3 2023 results Nov. 13

2023-11-07 16:53 ET - News Release

Mr. David Wolf reports

HAMILTON THORNE TO ANNOUNCE Q3 2023 FINANCIAL RESULTS AND HOLD CONFERENCE CALL ON NOVEMBER 13, 2023

Hamilton Thorne Ltd. will release its financial results for the three and nine months ended Sept. 30, 2023, before market open on Monday, Nov. 13, 2023. The press release, with accompanying financial information, will be posted on the company's website and SEDAR+.

The company will follow with a conference call on the same day at 9 a.m. ET to review highlights of the results. All interested parties are welcome to join the conference call by dialling toll-free 1-833-366-1126 in North America, or 1-412-317-0703 from other locations, and requesting the Hamilton Thorne conference call. The company's updated investor presentation and a recording of the call will be available on Hamilton Thorne's website shortly after the call.

About Hamilton Thorne Ltd.

Hamilton Thorne is a leading global provider of precision instruments, consumables, software and services that reduce cost, increase productivity, improve results and enable breakthroughs in assisted reproductive technologies (ART), research and cell biology markets. Hamilton Thorne markets its products and services under the Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, Microptic, Gynetics and Embryotech Laboratories brands, through its growing sales force and distributors worldwide. Hamilton Thorne's customer base consists of fertility clinics, university research centres, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments.

© 2024 Canjex Publishing Ltd. All rights reserved.